Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Brain Research|December 30, 1994
Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?A Mouatt-Prigent, Y Agid, E C HirschNeurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Synaptic plasticity in the caudate nucleus of patients with Parkinson's diseaseP Anglade, A Mouatt-Prigent, Y Agid, et al.Neuroscience|August 1, 1996
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?A Mouatt-Prigent, J O Karlsson, Y Agid, et al.Journal of Neural Transmission. Supplementum|January 1, 1997
Neuronal vulnerability in Parkinson's diseaseE C Hirsch, B Faucheux, P Damier, et al.The Journal of Comparative Neurology|March 21, 2000
Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's diseaseA Mouatt-Prigent, J O Karlsson, J Yelnik, et al.Neurology|January 24, 2002
FADD: A link between TNF family receptors and caspases in Parkinson's diseaseA Hartmann, A Mouatt-Prigent, B A Faucheux, et al.Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|November 1, 1994
High affinity neurotrophin receptors in cholinergic neurons in the human brainF Boissière, S Hunot, B Faucheux, et al.Neuroscience|May 1, 1996
Nitric oxide synthase and neuronal vulnerability in Parkinson's diseaseS Hunot, F Boissière, B Faucheux, et al.Journal of Neurochemistry|June 1, 1993
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's diseaseB A Faucheux, E C Hirsch, J Villares, et al.Neuroscience Letters|July 9, 1993
In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levelsM T Herrero, M Ruberg, E C Hirsch, et al.Pageof 2